On February 16, 2011, Xu, Kefu published a patent.Computed Properties of 23256-42-0 The title of the patent was Sulfamonomethoxine sodium and ampicillin sodium-containing medical composition for treating swine infectious atrophic rhinitis and its preparation method. And the patent contained the following:
The title medical composition is prepared from (by weight%) sulfamonomethoxine sodium 5-15, trimethoprim lactate 1-3, ampicillin sodium 3-8, sodium carbonate 5, sodium bicarbonate 5-15 and addnl. anhydrous glucose, and prepared by mixing above raw materials according to the formula. Sulfamonomethoxine sodium and ampicillin sodium as antigen components can effectively kill pathogenic microorganism and reduce drug resistance occurrence, and are effective for secondary infection, trimethoprim lactate has synergistic action on sulfamonomethoxine sodium and ampicillin sodium, sodium carbonate has solubilizing action on sulfamonomethoxine sodium and ampicillin sodium, and sodium bicarbonate alleviates side effect of sulfamonomethoxine sodium and prevents crystalluria occurrence. The experimental process involved the reaction of 5-(3,4,5-Trimethoxybenzyl)pyrimidine-2,4-diamine 2-hydroxypropanoate(cas: 23256-42-0).Computed Properties of 23256-42-0
The Article related to sulfamonomethoxine ampicillin swine infectious atrophic rhinitis, Pharmacology: Effects Of Antimicrobials and Parasiticides and other aspects.Computed Properties of 23256-42-0
Referemce:
Pyrimidine | C4H4N2 – PubChem,
Pyrimidine – Wikipedia